Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism Registry
Publisher DOI
PubMed ID
22908319
Abstract
Cardiac biomarkers and echocardiography for assessing right ventricular function are recommended to risk stratify patients with acute non-massive pulmonary embolism (PE), but it remains unclear if these tests are performed systematically in daily practice. Design and methods: Overall, 587 patients with acute non-massive PE from 18 hospitals were enrolled in the Swiss Venous Thromboembolism Registry (SWIVTER): 178 (30%) neither had a biomarker test nor an echocardiographic evaluation, 196 (34%) had a biomarker test only, 47 (8%) had an echocardiogram only and 166 (28%) had both tests.
Date Issued
2012
Publication Type
Article
Language(s)
en
Author(s)
Spirk, D | |
Willenberg, T | |
Husmann, M | |
Hayoz, D | |
Baldi, T | |
Brugger, A | |
Amann-Vesti, B | |
Kucher, N |
Additional Credits
Journal
QJM - an international journal of medicine
Publisher
Oxford University Press
ISSN
1460-2725
Access(Rights)
open.access